Latest Strategic Reviews News

Panther Metals has completed a $315k shortfall placement, bolstering its funding as it plans deeper drilling at Burtville East and initiates a strategic review of its Coglia project in response to soaring cobalt prices.

360 Capital Group (ASX, TGP) has received an unconditional on-market takeover bid from TT Investments at $0.31 per stapled security. The Independent Board Committee unanimously recommends acceptance, supported by an Independent Expert's fair and reasonable opinion.

Adisyn Ltd has completed a strategic review, deciding to boost investment in its graphene-based semiconductor arm while exploring options to unlock value from its managed IT services business.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

360 Capital Group has announced it will not pay a dividend for the first half of fiscal 2026, signaling a cautious approach amid an ongoing strategic review.

nib holdings limited signals higher-than-expected non-recurring expenses in the first half of 2026, impacting statutory profit but leaving underlying performance steady.

TT Investments, led by Executive Chairman Tony Pitt, has announced an unconditional all-cash on-market takeover offer for 360 Capital Group at $0.31 per security, representing a 24% premium to recent trading prices. The offer aims to consolidate ownership and may lead to delisting from the ASX.

SunRice reported a 14% rise in net profit for the first half of FY26 despite a revenue dip, reaffirming its growth outlook and updating paddy price guidance amid a forecast drier season.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

GrainCorp announces the sale of its Canadian joint venture GrainsConnect to Parrish & Heimbecker for C$150 million, alongside a trading update revealing lower expected grain receivals in Australia’s 2025-26 winter harvest.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

FireFly Metals has launched a dual capital raising initiative, combining a $5 million Share Purchase Plan for eligible shareholders and a C$15 million Canadian flow-through share offer, aimed at funding key development and exploration activities at its Green Bay Copper-Gold Project.